-
1
المؤلفون: Alessandro Conti, U. De Giorgi, Enrico Cortesi, Lorena Rossi, S Luca Burgio, Dino Amadori, Luciano Burattini, Matteo Santoni, Giovanni Muzzonigro, Rossana Berardi, Roberto Iacovelli, Stefano Cascinu
المصدر: British Journal of Cancer
مصطلحات موضوعية: Adult, Male, renal cell carcinoma, mTOR inhibitors, Cancer Research, medicine.medical_specialty, Pathology, Survival, Neutrophils, Colorectal cancer, Urology, Disease-Free Survival, tyrosine kinase inhibitor, neutrophil-to-lymphocyte ratio, Renal cell carcinoma, medicine, Humans, Everolimus, Lymphocyte Count, Lymphocytes, Neoplasm Metastasis, Neutrophil to lymphocyte ratio, Lung cancer, Carcinoma, Renal Cell, Aged, Aged, 80 and over, Sirolimus, targeted therapy, mtor inhibitors, everolimus, neutrophil-tolymphocyte ratio, business.industry, TOR Serine-Threonine Kinases, Middle Aged, medicine.disease, Kidney Neoplasms, Treatment Outcome, Oncology, Clinical Study, Female, Skin cancer, Liver cancer, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a063ad4216ed9b55fd7939f541fdd9Test
https://doi.org/10.1038/bjc.2013.522Test -
2
المؤلفون: Jonathan D. Cheng, Lainie P. Martin, J. Fiorica, Raanan Berger, Paul Haluska, William S. Dalton, M. B. Jones, Shannon N. Westin, Lillian L. Siu, Talia Golan, J. Stephenson, Jhanelle E. Gray, Khaldoun Almhanna, R. M. Wenham, P. Hanjani, Alexandra Gunchenko, Daniel M. Sullivan, J. Edenfield, Irene Brana
المصدر: British Journal of Cancer
مصطلحات موضوعية: Male, Cancer Research, Akt inhibitor, Pharmacology, Receptor, IGF Type 1, Cohort Studies, chemistry.chemical_compound, MK-0752, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Benzene Derivatives, Medicine, Tissue Distribution, Sulfones, Randomized Controlled Trials as Topic, Aged, 80 and over, biology, Receptors, Notch, TOR Serine-Threonine Kinases, Antibodies, Monoclonal, Middle Aged, Discovery and development of mTOR inhibitors, Prognosis, ovarian cancer, Oncology, MK-2206, Female, Antibody, Heterocyclic Compounds, 3-Ring, Adult, colorectal cancer, Antibodies, Monoclonal, Humanized, Ridaforolimus, Clinical Trials, Phase II as Topic, ridaforolimus, Biomarkers, Tumor, Humans, In patient, Aged, Neoplasm Staging, dalotuzumab, Sirolimus, business.industry, Dalotuzumab, chemistry, Clinical Trials, Phase III as Topic, biology.protein, Clinical Study, Propionates, business, Proto-Oncogene Proteins c-akt, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f49b7b9125e9a40ceec15ef2e49d7c9Test
http://europepmc.org/articles/PMC4229637Test -
3
المؤلفون: Razelle Kurzrock, Udai Banerji, Carol Aghajanian, David Olmos, Stan B. Kaye, Elisabeth Oelmann, Aung Naing, William L Burke, Robert H Taylor, Gary G Schwartz, Lynda Grinsted, Eric Raymond
المصدر: British Journal of Cancer
مصطلحات موضوعية: Drug, Adult, Male, Cancer Research, medicine.medical_specialty, mTOR inhibitors, Lymphoma, Maximum Tolerated Dose, media_common.quotation_subject, Morpholines, Mechanistic Target of Rapamycin Complex 2, Pharmacology, Mechanistic Target of Rapamycin Complex 1, Gastroenterology, Drug Administration Schedule, Cohort Studies, Stable Disease, Pharmacokinetics, Internal medicine, Neoplasms, Medicine, Humans, Dosing, Adverse effect, media_common, Aged, Dose-Response Relationship, Drug, business.industry, TOR Serine-Threonine Kinases, AZD8055, phase I, Middle Aged, medicine.disease, Oncology, Tolerability, Multiprotein Complexes, Elevated transaminases, Female, business, Translational Therapeutics
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a485a49be57a5c43fcb8ae4edd16f1Test
http://europepmc.org/articles/PMC3461162Test -
4
المؤلفون: Guru Sonpavde, Christopher J. Richards, Youjin Je, D Y C Heng, Toni K. Choueiri, Marina D. Kaymakcalan, Matthew D. Galsky, Paul L. Nguyen
المصدر: British Journal of Cancer
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Pathology, renal cell carcinoma, mTOR inhibitors, Subgroup analysis, Antineoplastic Agents, Infections, Gastroenterology, Clinical Trials, Phase II as Topic, Renal cell carcinoma, Risk Factors, Internal medicine, temsirolimus, medicine, Carcinoma, Humans, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Randomized Controlled Trials as Topic, Everolimus, business.industry, Genitourinary system, Incidence (epidemiology), TOR Serine-Threonine Kinases, medicine.disease, everolimus, Temsirolimus, Kidney Neoplasms, meta-analysis, medicine.anatomical_structure, Oncology, Clinical Trials, Phase III as Topic, business, Translational Therapeutics, medicine.drug, Respiratory tract
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea3994fb9aa4a1cf0ba020477cfae3fTest
https://pubmed.ncbi.nlm.nih.gov/23736025Test -
5
المؤلفون: Z Kherrouche, Alison L. Dahler, Liliana Endo-Munoz, Mehlika Hazar-Rethinam, Karen L. Wooley, Rafael B. Erlich, Danny Rickwood, L M de Long, Nicholas A. Saunders, S. Cameron, Alexander Guminski
المصدر: British Journal of Cancer
مصطلحات موضوعية: squamous cell carcinoma, Cancer Research, Pathology, medicine.medical_specialty, Indoles, Combination therapy, medicine.drug_class, Drug Evaluation, Preclinical, Mice, SCID, Biology, Hydroxamic Acids, combination therapy, 03 medical and health sciences, Mice, 0302 clinical medicine, Mice, Inbred NOD, Cell Line, Tumor, Panobinostat, medicine, Animals, Humans, histone deacetylase inhibitor, PI3K/AKT/mTOR pathway, 030304 developmental biology, Phosphoinositide-3 Kinase Inhibitors, 0303 health sciences, Vorinostat, TOR Serine-Threonine Kinases, Histone deacetylase inhibitor, medicine.disease, Discovery and development of mTOR inhibitors, Head and neck squamous-cell carcinoma, Immunohistochemistry, 3. Good health, Histone Deacetylase Inhibitors, stomatognathic diseases, Oncology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, phosphoinositol 3 kinase inhibitor, Cancer research, Carcinoma, Squamous Cell, Female, Histone deacetylase, Translational Therapeutics
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb8cba0006a59ee38d45f5f93b8d833Test
https://pubmed.ncbi.nlm.nih.gov/22116303Test